The relationship between obesity, breast cancer incidence/recurrence and prognosis is complex and may imply both direct mechanisms involving insulin, inflammation and estrogen levels and indirect mechanisms, including inadequate AI dosage, reduced compliance with therapy or insufficient inhibition of excess aromatase present in the adipose tissue of obese subjects [25]. This evidence concerns the gene CYP19A1 and obesity disorder.